Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Larimar Therapeutics, Inc. LRMR

Full chart Compare
Set alert

Price alert · LRMR

All alert types
2.70 USD +0.15 (+6.10%)

Nov 4, 2026, 12:01 PM EST

2.58 Day range 2.75
1.92 52-week range 6.42
YTD
-29.27%
1 year
-29.08%

Financial health

Altman Z-Score

-2.56 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -1.7×
FY 2016: -1.5×FY 2017: -2.4×FY 2018: -2.6×FY 2019: -5.3×FY 2020: -6.0×FY 2021: -3.7×FY 2022: -3.1×FY 2023: -5.4×FY 2024: -2.9×FY 2025: -1.7×
FY 2016 5y median -3.1× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.6×
FY 2016: 0.7×FY 2017: 1.6×FY 2018: 1.7×FY 2019: -177×FY 2020: 2.8×FY 2021: 2.9×FY 2022: 1.0×FY 2023: 2.4×FY 2024: 1.4×FY 2025: 3.6×
FY 2016 5y median 2.4× FY 2025
P/FCF -2.5×
FY 2016: -1.6×FY 2017: -2.9×FY 2018: -3.1×FY 2019: -5.4×FY 2020: -6.0×FY 2021: -4.4×FY 2022: -3.8×FY 2023: -5.9×FY 2024: -3.3×FY 2025: -2.5×
FY 2016 5y median -3.8× FY 2025
EV/EBITDA -1.2×
FY 2016: -1.0×FY 2017: -2.0×FY 2018: -2.2×FY 2019: -5.3×FY 2020: -4.5×FY 2021: -2.4×FY 2022: -2.4×FY 2023: -4.9×FY 2024: -2.6×FY 2025: -1.2×
FY 2016 5y median -2.4× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -40.8%
FY 2016: -60.6%FY 2017: -34.6%FY 2018: -32.3%FY 2019: -18.6%FY 2020: -16.6%FY 2021: -22.9%FY 2022: -26.0%FY 2023: -16.8%FY 2024: -30.1%FY 2025: -40.8%
FY 2016 5y median -26.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -212.2%
FY 2016: -47.5%FY 2017: -66.5%FY 2018: -65.8%FY 2019: 3333.1%FY 2020: -47.2%FY 2021: -78.6%FY 2022: -31.9%FY 2023: -45.2%FY 2024: -46.9%FY 2025: -212.2%
FY 2016 5y median -46.9% FY 2025
ROIC -210.0%
FY 2016: -45.3%FY 2017: -53.9%FY 2018: -53.7%FY 2019: 3888.4%FY 2020: -44.5%FY 2021: -71.7%FY 2022: -31.4%FY 2023: -47.9%FY 2024: -51.4%FY 2025: -210.0%
FY 2016 5y median -51.4% FY 2025
ROA -113.6%
FY 2016: -44.0%FY 2017: -49.3%FY 2018: -50.4%FY 2019: -444.8%FY 2020: -40.4%FY 2021: -64.4%FY 2022: -28.0%FY 2023: -38.5%FY 2024: -40.3%FY 2025: -113.6%
FY 2016 5y median -40.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -89.8%
FY 2016: 22.6%FY 2017: 5.7%FY 2018: -16.4%FY 2019: 63.0%FY 2020: -84.4%FY 2021: -17.9%FY 2022: 27.6%FY 2023: -14.3%FY 2024: -117.7%FY 2025: -89.8%
FY 2016 FY 2025
EPS (diluted) -72.0%
FY 2016: 23.6%FY 2017: 10.5%FY 2018: -0.4%FY 2019: 89.0%FY 2020: -41.8%FY 2021: 17.7%FY 2022: 54.6%FY 2023: 36.8%FY 2024: -57.1%FY 2025: -72.0%
FY 2016 FY 2025
Free Cash Flow -59.0%
FY 2016: 12.5%FY 2017: 16.7%FY 2018: -17.7%FY 2019: 55.8%FY 2020: -85.5%FY 2021: -0.4%FY 2022: 34.8%FY 2023: -21.5%FY 2024: -112.0%FY 2025: -59.0%
FY 2016 FY 2025

Financial Health

Current Ratio 2.2×
FY 2016: 13.2×FY 2017: 14.4×FY 2018: 9.1×FY 2019: 0.8×FY 2020: 10.9×FY 2021: 8.2×FY 2022: 11.3×FY 2023: 9.5×FY 2024: 8.0×FY 2025: 2.2×
FY 2016 5y median 8.2× FY 2025
Quick Ratio 2.2×
FY 2016: 13.2×FY 2017: 14.4×FY 2018: 9.1×FY 2019: 0.8×FY 2020: 10.9×FY 2021: 8.2×FY 2022: 11.3×FY 2023: 9.5×FY 2024: 8.0×FY 2025: 2.2×
FY 2016 5y median 8.2× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.3×FY 2018: 0.2×FY 2019: -0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 0.5×FY 2017: 0.4×FY 2018: 0.5×FY 2019: 0.0×FY 2020: 1.4×FY 2021: 1.3×FY 2022: 0.6×FY 2023: 0.6×FY 2024: 0.4×FY 2025: 0.5×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2016: -165×FY 2017: -55.5×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31